Trial
NCT01632436
Pharmacokinetic and Safety Study of Pixantrone in Patients With Metastatic Cancer and Hepatic Impairment
Phase IWITHDRAWNSAFETYConfidence: MEDIUM
Sponsor
CTI BioPharma
Collaborators
—
Condition
Metastatic Cancer
Intervention
Pixantrone
Why stopped
No eligible patients enrolled
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-10-02